A total of 152 deals were announced in the global healthcare sector, including pharmaceuticals and medical equipment, during the week ended March 29, which represents an increase of 23.6% over the 123 deals announced the previous week, according to GlobalData’s deals database.

Aurojyoti Bose, Analyst at GlobalData, comments: “While deal activity remained subdued globally on the back of volatile market conditions, due to the outbreak of the coronavirus (COVID-19), the healthcare sector showcased resillence and witnessed growth in deal activity after witnessing decline during previous two weeks.

“Deal activity remained mostly flat in China, while other key markets such as the US and the UK witnessed growth in deal activity during the week ended March 29.”

Announcement of equity offerings, licensing agreements, partnerships and private equity deals increased by 81.8%, 130%, 29.6% and 50%, respectively, while venture financing and merger and acquisitions (M&A) deals volume dropped by 25% and 50%, respectively.